MUFG Securities Americas’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Buy
61,504
+5,154
+9% +$296K 0.18% 98
2026
Q1
$3.42M Buy
56,350
+1,506
+3% +$87.8K 0.22% 82
2025
Q4
$2.96M Sell
54,844
-44
-0.1% -$2.12K 0.18% 104
2025
Q3
$2.48M Buy
54,888
+9,785
+22% +$457K 0.16% 118
2025
Q2
$2.09M Buy
45,103
+9,182
+26% +$451K 0.18% 111
2025
Q1
$2.19M Buy
35,921
+5,982
+20% +$349K 0.25% 83
2024
Q4
$1.69M Buy
+29,939
New +$1.67M 0.21% 90

Other funds holding BMY

MUFG Securities Americas's BMY Position: Q2 2026 in Review

MUFG Securities Americas increased its Bristol-Myers Squibb (BMY) stake by 9.1% in Q2 2026, buying an estimated $296K and bringing the position to 61,504 shares worth $3.54M. The position accounts for 0.18% of the portfolio, ranked #98.

MUFG Securities Americas first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MUFG Securities Americas held 61,504 shares of Bristol-Myers Squibb worth $3.54M as of Q2 2026.
  • MUFG Securities Americas bought 5,154 Bristol-Myers Squibb shares in Q2 2026, an estimated $296K.
  • Bristol-Myers Squibb made up 0.18% of MUFG Securities Americas's portfolio in Q2 2026, its #98 holding.
  • MUFG Securities Americas first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.